EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study

Marc Blondon, Maud Lansiaux, Saskia Bryan, Amélie Dongala, Romain Pavoncello, Gilles Chatellier, Marine Claver, Elie Azria, Begoña Martinez de Tejada, Justine Hugon-Rodin

Journal of Thrombosis and Haemostasis · 2024

DOI: 10.1016/j.jtha.2024.06.019 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Marc Blondon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Angiology and Hemostasis, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland. Electronic address: marc.blondon@h…. Hauptthemen laut MEDLINE: Anticoagulants, Heparin, Low-Molecular-Weight, Patient Preference, Postpartum Hemorrhage. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hologic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clinical guidelines for postpartum thromboprophylaxis differ due to its uncertain effect and varying preferences of experts. Women's preferences for postpartum thromboprophylaxis are unknown, although they may inform practices and future research. OBJECTIVES: Our aim was to elicit the pregnant women's preferences for postpartum thromboprophylaxis according to different risks of venous thromboembolism (VTE) and bleeding. METHODS: In 2 Swiss and French maternity hospitals, we conducted structured interviews of pregnant or postpartum women. Participants were instructed on pulmonary embolism, deep vein thrombosis, postpartum hemorrhage, and subcutaneous injections of low-molecular-weight heparin (LMWH). First, we randomized women to either standard gamble or time trade-off (2 different validated methods) to estimate the utilities (quality of life, from 0 to 1) of these health states. Second, we elicited the preference for the use of short-term postpartum thromboprophylaxis with LMWH vs none across different risks of postpartum VTE and bleeding through direct-choice exercises. RESULTS: Among 122 participants, median (IQR) health state utilities were 0.725 (0.30-0.925) for pulmonary embolism, 0.75 (0.40-0.97) for postpartum hemorrhage, 0.85 (0.60-0.97) for deep vein thrombosis, and 0.96 (0.96-0.999) for LMWH injections. The median risk of postpartum VTE for preference of the use of postpartum thromboprophylaxis over no treatment was 0.1% (IQR, 0.01%-0.50%) without LMWH-associated bleeding risk and 0.2% (IQR, 0.1%-5%) with a 1% bleeding risk. CONCLUSION: European pregnant women appear to have a high willingness for 10-day postpartum thromboprophylaxis, preferred over no treatment even for low risks of postpartum VTE. This perspective from patients supports the urgent need for a randomized trial evaluating the efficacy and safety of postpartum thromboprophylaxis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsHeparin, Low-Molecular-WeightPatient PreferencePostpartum HemorrhagePostpartum PeriodVenous ThromboembolismAdultFemaleHumansPregnancyFranceHospitals, MaternityInjections, SubcutaneousPulmonary EmbolismQuality of LifeRisk AssessmentRisk FactorsSwitzerlandVenous Thrombosis

Stichwörter der Autor:innen

low-molecular-weight heparinpatient preferencepostpartum periodpregnancyvenous thromboembolism

Substanzen

AnticoagulantsHeparin, Low-Molecular-Weight

Autor:innen und Institutionen

  • Division of Angiology and Hemostasis, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland. Electronic address: marc.blondon@hcuge.ch.
  • Gynecology Department, Gynaecological Endocrinology Unit, Hospital Saint Joseph, Paris, France.
  • Faculty of Medicine, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland.
  • Clinical Research Unit, Paris Saint Joseph Hospital, Paris, France.
  • Division of Obstetrics, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland.
  • Maternity Unit, Paris Saint Joseph Hospital, Fédération Hospitalo-Universitaire Combattre la prématurité, Paris, France; Université de Paris Cité, Centre de Recherche en Epidémiologie et Statistiques, Obstetrical Perina…

Förderung

  • Hologic

Zitieren

APA

Blondon, M., Lansiaux, M., Bryan, S., Dongala, A., Pavoncello, R., Chatellier, G., Claver, M., Azria, E., Martinez de Tejada, B., & Hugon-Rodin, J. (2024). Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.06.019

Vancouver

Blondon M, Lansiaux M, Bryan S, Dongala A, Pavoncello R, Chatellier G, et al. Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.06.019

BibTeX
@article{Blondon2024,
  author = {Blondon, Marc and Lansiaux, Maud and Bryan, Saskia and Dongala, Amélie and Pavoncello, Romain and Chatellier, Gilles and Claver, Marine and Azria, Elie and Martinez de Tejada, Begoña and Hugon-Rodin, Justine},
  title = {Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  doi = {10.1016/j.jtha.2024.06.019}
}
Kostenlos starten →